Roche has signed a development and collaboration agreement with Novo Nordisk, a leader in innovating the therapy of diabetes and obesity. Under the terms of the development and collaboration agreement, the partners will integrate insulin data from Novo Nordisk's connected pen to Roche's open ecosystem, synchronizing with its suite of digital diabetes management solutions including mySugr.People with diabetes spend an average of one hour per day on self-care and have to make up to 50 therapy
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
10 Major Trends Shaping The Global Digital Diabetes Market
In the last two years, the digital diabetes care market has seen a substantial progress. In the new report, Digital Diabetes Care Market 2018-2022: Ready to Take Off, Research2Guidance demonstrates how the improvement of digital diabetes solutions has resulted in the increasing demand for them among patients and healthcare organizations. According to the report, the digital diabetes care market has reached a tipping point, which will result in the sustainable growth in the
Read More
Novo Nordisk Launches the Innovation Challenge Focused on Diabetes Management
Novo Nordisk, a global leader in the diabetes space, is seizing the opportunity to advance care and leverage digital health technology through the Novo Nordisk Innovation Challenge. With support from MATTER, a prominent incubator and innovation hub, Novo Nordisk is challenging start-ups, researchers, entrepreneurs, and students to explore, design; and co-develop digital health solutions for the more than 400 million people living with diabetes worldwide.The first phase of the challenge is
Read More
Livongo Health and Abbott Partner to Offer Continuous Glucose Monitoring Insights
Livongo Health, a consumer digital health company empowering people with chronic conditions to live better and healthier lives, today announced that it will be the first comprehensive offering for people with diabetes to integrate continuous glucose data from Abbott’s FreeStyle® Libre Pro System, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals.Through this integration collaboration, Livongo will offer, where appropriate and prescribed, the FreeStyle Libre
Read More
iGlucose Integrates with Validic’s Data Connectivity Platform to Simplify Diabetes Management
Smart Meter, LLC, makers of the iGlucose® Cellular Diabetes Care Solution, announced its integration with Validic, a healthcare data connectivity platform. The integration brings a simple, convenient and affordable diabetes management solution to people with diabetes, healthcare teams, and population management programs. The iGlucose solution, which uses cell-enabled technology to automatically transmit real-time blood glucose results, removes complex technology issues by automatically
Read More
Rimidi Raises $6.575M for Cloud-based Enterprise Solution for Diabetes Management
Rimidi, Inc.(formerly known as Rimidi Diabetes), an Atlanta-based digital health startup that provides software and clinical analytics for chronic disease management, announced it has raised $6.575 million in Series A-1 financing, which includes a strategic investment by Eli Lilly and Company, an investment from Turner Investments, and participation from existing investors Cox Enterprises, Village Capital, The Jump Fund, and JAMB Global. The company plans to use the funding round to fuel growth
Read More
Duke Health to Integrate Glytecc’s Insulin Management with Epic EMR
Duke University Health System has selected Glytec’s eGlycemic Management System to elevate the quality and safety of care for patients with diabetes and others who require insulin therapy. With national statistics indicating that one of every three hospitalized patients requires insulin therapy during their stay, administering the right dose at the right time in accordance with best practices is integral to safe, effective care and speedy recovery. By implementing Glytec’s FDA-cleared eGlycemic
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
BioTel Care Unveils Next-Gen Wireless Blood Glucose Monitor for Diabetes Management
BioTel CareTM (formally known as Telcare), a BioTelemetry company has announced the release of its next-generation wireless blood glucose monitor for diabetes management. BioTel Care developed the first FDA-cleared, cellular-enabled glucometer which supports real-time transmission and consolidation of patient data in an FDA-cleared cloud. Building on the success of this technology, BioTel Care is launching its next-generation blood glucose monitor, which includes an innovative touch-screen user
Read More
New Study Reveals Personalization is Key to Diabetes Management
New study led by Livongo demonstrates that personalization is key to diabetes management and short periods of intensive coaching when people get stuck on their way to their glucose and weight goals can be helpful. A new study reveals that use of Livongo for Diabetes significantly improves the health of people with type 2 diabetes (T2D), according to recent findings reported in the Journal of Diabetes Research. Researchers also found pairing participation in Livongo for Diabetes with lifestyle
Read More